<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02638623</url>
  </required_header>
  <id_info>
    <org_study_id>1502590723</org_study_id>
    <nct_id>NCT02638623</nct_id>
  </id_info>
  <brief_title>Does Fluid Replacement From Preoperative NPO Status Improve Postoperative Recovery</brief_title>
  <acronym>Hydration</acronym>
  <official_title>Does Fluid Replacement From Preoperative NPO Status Improve Postoperative Recovery and Reduce Complications in Arthroplasty Patients?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>West Virginia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>West Virginia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are testing the hypothesis that administering 2L of body temperature warmed&#xD;
      lactated ringer's intravenously prior to surgery can optimize the postoperative and recovery&#xD;
      of patients undergoing total hip and total knee arthroplasty.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hip and knee arthroplasty are safe and reliable surgeries for the majority of patients, but a&#xD;
      small percentage experience major complications such as myocardial infarction, deep vein&#xD;
      thrombosis (DVT), and pulmonary embolism (PE). As these complications are related to local&#xD;
      tissue hypoxemia and patient immobility, interventions that can improve the ability of the&#xD;
      heart to deliver blood to the tissue and help patients mobilize earlier in their&#xD;
      postoperative course may decrease these complications. Based on recent evidence, it has been&#xD;
      shown that many patients are dehydrated before surgery, which can make them feel nauseous,&#xD;
      tired, and increase their perception of pain making them less likely to mobilize. This&#xD;
      predisposes them to DVTs, pulmonary embolism, nausea and vomiting. Peri-operative dehydration&#xD;
      can also decrease the ability of the lungs to oxygenate the blood properly and can place&#xD;
      additional stress on the heart, which can increase the risk of heart attacks. The specific&#xD;
      aim is to determine if patients' peri-operative hemodynamics can be improved with&#xD;
      preoperative administration of 2 L of lactated ringers, and consequently reduce postoperative&#xD;
      complications and improve recovery in arthroplasty patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Postoperative Complications</measure>
    <time_frame>90 days post surgery</time_frame>
    <description>Patients found to have a 90-day postoperative complication categorized as Infection, CHF/Fluid overload, MI, DVT/PE, other</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>90 Day Readmission Count</measure>
    <time_frame>90 days postop</time_frame>
    <description>Patient readmitted to the hospital 90 day postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Hospital Stay (Hours)</measure>
    <time_frame>Surgery to hospital discharge</time_frame>
    <description>Hours of Hospital Stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Surgery</measure>
    <time_frame>Incision to end of surgery</time_frame>
    <description>Minutes recorded for length of surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emesis Episodes</measure>
    <time_frame>Hospital Stay</time_frame>
    <description>Number of recorded emesis episodes in the medical record while patient was hospitalized</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of Fluid Administred</measure>
    <time_frame>surgical period</time_frame>
    <description>milliliters of fluid administered during surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Drug Lactated Ringer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Covered two liters of body temperature warmed lactated ringer's in the immediate preoperative setting of subjects undergoing total knee or total hip replacement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Covered empty bag with no hydration supplement</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactated Ringer</intervention_name>
    <description>2L Lactated Ringer administered prior to primary knee or hip arthroplasty</description>
    <arm_group_label>Drug Lactated Ringer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>No additional fluids will be administered</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients &gt;= 18 years of age, undergoing a total primary knee or hip arthroplasty&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients weighing less than 80 kg.&#xD;
&#xD;
          -  Patients undergoing irrigation and debridement, explantation, or revision will not be&#xD;
             eligible.&#xD;
&#xD;
          -  history of kidney disease, congestive heart failure, pulmonary edema, cirrhosis of the&#xD;
             liver, or history of systemic fluid overloard will be excluded from the study.&#xD;
&#xD;
          -  No one will be excluded based on gender, ethnicity or race.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew J Dietz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>West Virginia University Department of Orthopaedics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>WVU Medicine Department of Orthopaedics</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>December 18, 2015</study_first_submitted>
  <study_first_submitted_qc>December 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2015</study_first_posted>
  <results_first_submitted>February 15, 2019</results_first_submitted>
  <results_first_submitted_qc>September 30, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 23, 2020</results_first_posted>
  <last_update_submitted>November 4, 2020</last_update_submitted>
  <last_update_submitted_qc>November 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>West Virginia University</investigator_affiliation>
    <investigator_full_name>Matthew Dietz, MD</investigator_full_name>
    <investigator_title>Assistant Professor, MD</investigator_title>
  </responsible_party>
  <keyword>Knee Arthroplasty</keyword>
  <keyword>Hip Arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Lactated Ringer Bolus Group</title>
          <description>Covered two liters of body temperature warmed lactated ringer's in the immediate preoperative setting of subjects undergoing total knee or total hip replacement&#xD;
Lactated Ringer: 2L Lactated Ringer administered prior to primary knee or hip arthroplasty</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Covered empty bag with no hydration supplement&#xD;
Placebo: No additional fluids will be administered</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Surgery timing</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Not given intervention</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Lactated Ringer Bolus Group</title>
          <description>Covered two liters of body temperature warmed lactated ringer's in the immediate preoperative setting of subjects undergoing total knee or total hip replacement&#xD;
Lactated Ringer: 2L Lactated Ringer administered prior to primary knee or hip arthroplasty</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Covered empty bag with no hydration supplement&#xD;
Placebo: No additional fluids will be administered</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="19"/>
            <count group_id="B3" value="39"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>52 participants were initially enrolled. Patients that did not have surgery were removed from the analysis. Also, there were a few instances where there was not adequate staffing to fulfill the protocols needs.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>52 participants were initially enrolled. Patients that did not have surgery were removed from the analysis. Also, there were a few instances where there was not adequate staffing to fulfill the protocols needs.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <population>52 participants were initially enrolled. Patients that did not have surgery were removed from the analysis. Also, there were a few instances where there was not adequate staffing to fulfill the protocols needs.</population>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Surgical Procedure</title>
          <population>52 participants were initially enrolled. Patients that did not have surgery were removed from the analysis. Also, there were a few instances where there was not adequate staffing to fulfill the protocols needs.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hip Replacement</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Knee Replacement</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Postoperative Complications</title>
        <description>Patients found to have a 90-day postoperative complication categorized as Infection, CHF/Fluid overload, MI, DVT/PE, other</description>
        <time_frame>90 days post surgery</time_frame>
        <population>Chart review for patients up to 90 days after surgery documenting the above complications.</population>
        <group_list>
          <group group_id="O1">
            <title>Lactated Ringer Bolus Group</title>
            <description>Covered two liters of body temperature warmed lactated ringer's in the immediate preoperative setting of subjects undergoing total knee or total hip replacement&#xD;
Lactated Ringer: 2L Lactated Ringer administered prior to primary knee or hip arthroplasty</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Covered empty bag with no hydration supplement&#xD;
Placebo: No additional fluids will be administered</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Postoperative Complications</title>
          <description>Patients found to have a 90-day postoperative complication categorized as Infection, CHF/Fluid overload, MI, DVT/PE, other</description>
          <population>Chart review for patients up to 90 days after surgery documenting the above complications.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Wound Infection</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DVT/PE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>MI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CHF/Fluid Overload</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>90 Day Readmission Count</title>
        <description>Patient readmitted to the hospital 90 day postoperatively</description>
        <time_frame>90 days postop</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactated Ringer Bolus Group</title>
            <description>Covered two liters of body temperature warmed lactated ringer's in the immediate preoperative setting of subjects undergoing total knee or total hip replacement&#xD;
Lactated Ringer: 2L Lactated Ringer administered prior to primary knee or hip arthroplasty</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Covered empty bag with no hydration supplement&#xD;
Placebo: No additional fluids will be administered</description>
          </group>
        </group_list>
        <measure>
          <title>90 Day Readmission Count</title>
          <description>Patient readmitted to the hospital 90 day postoperatively</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Readmission</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No Readmission</title>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Hospital Stay (Hours)</title>
        <description>Hours of Hospital Stay</description>
        <time_frame>Surgery to hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactated Ringer Bolus Group</title>
            <description>Covered two liters of body temperature warmed lactated ringer's in the immediate preoperative setting of subjects undergoing total knee or total hip replacement&#xD;
Lactated Ringer: 2L Lactated Ringer administered prior to primary knee or hip arthroplasty</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Covered empty bag with no hydration supplement&#xD;
Placebo: No additional fluids will be administered</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Hospital Stay (Hours)</title>
          <description>Hours of Hospital Stay</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.86" lower_limit="26" upper_limit="169"/>
                    <measurement group_id="O2" value="36.13" lower_limit="24" upper_limit="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Surgery</title>
        <description>Minutes recorded for length of surgery</description>
        <time_frame>Incision to end of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactated Ringer Bolus Group</title>
            <description>Covered two liters of body temperature warmed lactated ringer's in the immediate preoperative setting of subjects undergoing total knee or total hip replacement&#xD;
Lactated Ringer: 2L Lactated Ringer administered prior to primary knee or hip arthroplasty</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Covered empty bag with no hydration supplement&#xD;
Placebo: No additional fluids will be administered</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Surgery</title>
          <description>Minutes recorded for length of surgery</description>
          <units>Minutes</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122.68" lower_limit="87" upper_limit="172"/>
                    <measurement group_id="O2" value="126.3" lower_limit="102" upper_limit="158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Emesis Episodes</title>
        <description>Number of recorded emesis episodes in the medical record while patient was hospitalized</description>
        <time_frame>Hospital Stay</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactated Ringer Bolus Group</title>
            <description>Covered two liters of body temperature warmed lactated ringer's in the immediate preoperative setting of subjects undergoing total knee or total hip replacement&#xD;
Lactated Ringer: 2L Lactated Ringer administered prior to primary knee or hip arthroplasty</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Covered empty bag with no hydration supplement&#xD;
Placebo: No additional fluids will be administered</description>
          </group>
        </group_list>
        <measure>
          <title>Emesis Episodes</title>
          <description>Number of recorded emesis episodes in the medical record while patient was hospitalized</description>
          <units>emesis episodes</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.26" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="0.11" lower_limit="0" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Volume of Fluid Administred</title>
        <description>milliliters of fluid administered during surgery</description>
        <time_frame>surgical period</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactated Ringer Bolus Group</title>
            <description>Covered two liters of body temperature warmed lactated ringer's in the immediate preoperative setting of subjects undergoing total knee or total hip replacement&#xD;
Lactated Ringer: 2L Lactated Ringer administered prior to primary knee or hip arthroplasty</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Covered empty bag with no hydration supplement&#xD;
Placebo: No additional fluids will be administered</description>
          </group>
        </group_list>
        <measure>
          <title>Volume of Fluid Administred</title>
          <description>milliliters of fluid administered during surgery</description>
          <units>milliliters</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1635" lower_limit="400" upper_limit="4750"/>
                    <measurement group_id="O2" value="1518" lower_limit="700" upper_limit="2600"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>90 Days postoperatively</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Lactated Ringer Bolus Group</title>
          <description>Covered two liters of body temperature warmed lactated ringer's in the immediate preoperative setting of subjects undergoing total knee or total hip replacement&#xD;
Lactated Ringer: 2L Lactated Ringer administered prior to primary knee or hip arthroplasty</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Covered empty bag with no hydration supplement&#xD;
Placebo: No additional fluids will be administered</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Matthew J. Dietz, MD</name_or_title>
      <organization>West Virginia University Department of Orthopaedics</organization>
      <phone>304-285-7445</phone>
      <email>mdietz@hsc.wvu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

